Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Clinical trial NCT03245736 · COMPLETED

Trial details

NCT number: NCT03245736
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovary Cancer Cervix Cancer Endometrium Cancer Bladder Cancer Prostate Cancer Esophagus Cancer Lung Cancer, Nonsmall Cell Squamous Cell Carcinoma of the Head and Neck

Start date: 2017-08-23
Primary completion: 2019-01-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.